Friday, May 14, 2021 at 8:00 AM
This grand round has already taken place.
May 14th, 2021 1.00 AMA PRA Category 1 Credit Hours
Description
A discussion on a rationale for the use of targeted therapies in myasthenia gravis
Dates and Times
Start: 5/14/2021 8:00 AM
End: 5/14/2021 9:00 AM
Objectives
- To recognize the disease burden of patients with myasthenia gravis
- To recognize the role of complement inhibition in the treatment of myasthenia gravis
- To recognize the potential role of FcRn inhibition in the treatment of myasthenia gravis
Speakers
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Dawn Caffrey
Department: Neurology
Phone: (631) 444-2694
Email: dawn.caffrey@stonybrookmedicine.edu